This article is from the source 'guardian' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.theguardian.com/science/2019/oct/07/nobel-prize-in-medicine-awarded-to-hypoxia-researchers
The article has changed 7 times. There is an RSS feed of changes available.
| Version 1 | Version 2 |
|---|---|
| Nobel prize in medicine awarded to hypoxia researchers | Nobel prize in medicine awarded to hypoxia researchers |
| (32 minutes later) | |
| Three scientists have shared this year’s Nobel prize in physiology or medicine for discovering how the body responds to changes in oxygen levels, one of the most essential processes for life. | Three scientists have shared this year’s Nobel prize in physiology or medicine for discovering how the body responds to changes in oxygen levels, one of the most essential processes for life. |
| William Kaelin Jr at the Dana Farber Cancer Institute and Harvard University in Massachusetts; Sir Peter Ratcliffe at Oxford University and the Francis Crick Institute in London; and Gregg Semenza at Johns Hopkins University in Baltimore, Maryland, worked out how cells sense falling oxygen levels and respond by making new blood cells and vessels. | |
| Beyond describing a fundamental physiological process that enables animals to thrive in some of the highest regions on Earth, the mechanism has given researchers new routes to treatments for anaemia, cancer, heart disease and other conditions. | Beyond describing a fundamental physiological process that enables animals to thrive in some of the highest regions on Earth, the mechanism has given researchers new routes to treatments for anaemia, cancer, heart disease and other conditions. |
| Ratcliffe was summoned from a lab meeting in Oxford to take the call from Stockholm. “I tried to make sure it wasn’t some friend down the road having a laugh at my expense,” he told the Guardian. “Then I accepted the news and had a think about how I was going to reorder my day.” | |
| Ratcliffe had spent the weekend working on an EU synergy grant and despite winning the prestigious Lasker prize with Kaelin and Semenza in 2016, had not imagined his morning taking such a turn. “When I got up this morning I didn’t have any expectation or make any contingency plans for the announcement at all,” he said. | |
| On finishing the call, he returned to his meeting and, at the request of the Nobel committee, carried on without a word. At least one scientist had her suspicions however, having noticed that he left a coffee in the room and returned with a tea. “She’s a scientist so trained to draw deductions from the things she observes,” Ratcliffe said. “I’d decided I needed a little less agitation rather than more.” | |
| The three laureates will share the 9m Swedish kronor (£740,000) equally, according to the Karolinska Institute in Stockholm. Asked what he intended to do with the windfall, Ratcliffe said: “I’ll be discussing that with my wife in private. But it’ll be something good.” | |
| Kaelin was half-asleep when his phone went. “I was aware as a scientist that if you get a phone call at 5am with too many digits, it’s sometimes very good news, and my heart started racing,” he said. “It was all a bit surreal.” | |
| In work that spanned more than two decades, the researchers teased apart different aspects of how cells in the body first sense and then respond to low oxygen levels. The gas is used by tiny structures called mitochondria found in nearly all animal cells to convert food into useful energy. | |
| hypoxia-induced factor (HIF) | |
| When the amount of oxygen available to cells drops, levels of a protein complex named HIF rise. This ramps up the activity of a gene used in the production of erythropoietin (EPO), a hormone that in turn boosts the creation of red blood cells. | When the amount of oxygen available to cells drops, levels of a protein complex named HIF rise. This ramps up the activity of a gene used in the production of erythropoietin (EPO), a hormone that in turn boosts the creation of red blood cells. |
| Randall Johnson, professor of molecular physiology and pathology at Cambridge University, said this year’s Nobel laureates “have greatly expanded our knowledge of how physiological response makes life possible.” | Randall Johnson, professor of molecular physiology and pathology at Cambridge University, said this year’s Nobel laureates “have greatly expanded our knowledge of how physiological response makes life possible.” |
| The role of HIF is crucial from the earliest days of life, Randall said. “If an embryo doesn’t have the HIF gene it won’t survive past very early embryogenesis. Even in the womb our bodies need this gene to do everything they do.” | The role of HIF is crucial from the earliest days of life, Randall said. “If an embryo doesn’t have the HIF gene it won’t survive past very early embryogenesis. Even in the womb our bodies need this gene to do everything they do.” |
| The work has already led to a swathe of drugs, such as roxadustat and daprodustat, which treat anaemia by fooling the body into thinking it is at high altitude, making it churn out more oxygen-carrying red blood cells. But similar drugs aim to help heart disease and lung cancer patients who struggle to get enough oxygen into their blood stream. More experimental drugs based on the finding seek to prevent cancers from growing by blocking their ability to make new blood vessels. | |
| Nobel prizes | Nobel prizes |
| Medical research | Medical research |
| Sweden | Sweden |
| Europe | Europe |
| People in science | People in science |
| Science prizes | Science prizes |
| news | news |
| Share on Facebook | Share on Facebook |
| Share on Twitter | Share on Twitter |
| Share via Email | Share via Email |
| Share on LinkedIn | Share on LinkedIn |
| Share on Pinterest | Share on Pinterest |
| Share on WhatsApp | Share on WhatsApp |
| Share on Messenger | Share on Messenger |
| Reuse this content | Reuse this content |